Cesar Ceballos, MD
Orthopaedic Surgery · Miami, FLNPI 1952366502
Payments from drug & device makers
Across 96 payments — averaging $104.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$7K
- Miach Orthopaedics, Inc.$677
- Johnson & Johnson$376
- Zimmer Biomet$268
- Vericel Corporation$160
- Biotronik NRO, Inc.$160
- plus $1K from 22 others
What the payments were for
- Consulting fees$3,10031%
- Speaking & faculty fees$1501%
- Travel & lodging$1,02510%
- Food & beverage$3,38834%
- Education$2,34723%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 29 | $7,261 |
| Miach Orthopaedics, Inc. | 3 | $677 |
| Johnson & Johnson | 13 | $376 |
| Zimmer Biomet | 4 | $268 |
| Vericel Corporation | 8 | $160 |
| Biotronik NRO, Inc. | 5 | $160 |
| Bard Peripheral Vascular, Inc. | 6 | $159 |
| Southern Edge Orthopaedics, Inc. | 1 | $154 |
| Pacira Pharmaceuticals Incorporated | 2 | $137 |
| Kowa Pharmaceuticals America, Inc. | 4 | $69 |
| Aroa Biosurgery Incorporated | 1 | $67 |
| Embody, Inc. | 1 | $60 |
| Stryker | 1 | $55 |
| KCI USA, Inc. | 2 | $37 |
| Electronic Waveform Lab, Inc. | 2 | $37 |
| Saluda Medical Americas, Inc. | 1 | $37 |
| Bioventus LLC | 2 | $33 |
| Medtronic | 1 | $31 |
| AbbVie | 1 | $30 |
| Treace Medical Concepts, Inc. | 1 | $30 |
| Organogenesis Inc. | 1 | $27 |
| Amgen | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $23 |
| Smith+Nephew | 1 | $23 |
| Avanos Medical | 1 | $22 |
| Pacira Therapeutics, Inc. | 1 | $20 |
| Anika Therapeutics, Inc. | 1 | $19 |
| Curonix LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$122
How this compares
$10,011 in reported general payments places this provider in the 60th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 102 | $772 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $146 |
| Methylprednisolone | 12 | $106 |
| Meloxicam | 19 | $50 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Miami
- Charles LawrieMiami$1.7M
- Rolando GarciaMiami$1M
- Charles JordanMiami$817K
- Francis HornicekMiami$790K
- Aldo RiesgoMiami$709K
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$35M
- Mark FrankleTemple Terrace$31.4M
- David WatsonTemple Terrace$21M
- Roy SandersTemple Terrace$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.